Publication

Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine beta-Hydroxylase Knockout Mice

Downloadable Content

Persistent URL
Last modified
  • 02/25/2025
Type of Material
Authors
    Joseph Cubells, Emory UniversityJason Schroeder, Emory UniversityElizabeth S. Barrie, Ohio State UniversityDaniel F. Manvich, Emory UniversityWolfgang Sadee, Ohio State UniversityTiina Berg, Emory UniversityKristina Mercer, Emory UniversityTaylor A. Stowe, Emory UniversityL. Cameron Liles, Emory UniversityKatherine E. Squires, Emory UniversityAndrew Mezher, Emory UniversityPatrick Curtin, Emory UniversityDannie L. Perdomo, Emory UniversityPatricia Szot, VA Puget Sound Health Care SystemDavid Weinshenker, Emory University
Language
  • English
Date
  • 2016-05-05
Publisher
  • Public Library of Science
Publication Version
Copyright Statement
  • This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1932-6203
Volume
  • 11
Issue
  • 5
Start Page
  • e0154864
End Page
  • e0154864
Grant/Funding Information
Abstract
  • Dopamine β-hydroxylase (DBH) converts dopamine (DA) to norepinephrine (NE) in noradrenergic/adrenergic cells. DBH deficiency prevents NE production and causes sympathetic failure, hypotension and ptosis in humans and mice; DBH knockout (Dbh -/-) mice reveal other NE deficiency phenotypes including embryonic lethality, delayed growth, and behavioral defects. Furthermore, a single nucleotide polymorphism (SNP) in the human DBH gene promoter (-970C>T; rs1611115) is associated with variation in serum DBH activity and with several neurological- and neuropsychiatric-related disorders, although its impact on DBH expression is controversial. Phenotypes associated with DBH deficiency are typically treated with L-3,4-dihydroxyphenylserine (DOPS), which can be converted to NE by aromatic acid decarboxylase (AADC) in the absence of DBH. In this study, we generated transgenic mice carrying a human bacterial artificial chromosome (BAC) encompassing the DBH coding locus as well as ~45 kb of upstream and ~107 kb of downstream sequence to address two issues. First, we characterized the neuroanatomical, neurochemical, physiological, and behavioral transgenic rescue of DBH deficiency by crossing the BAC onto a Dbh -/- background. Second, we compared human DBH mRNA abundance between transgenic lines carrying either a "C" or a "T" at position -970. The BAC transgene drove human DBH mRNA expression in a pattern indistinguishable from the endogenous gene, restored normal catecholamine levels to the peripheral organs and brain of Dbh -/- mice, and fully rescued embryonic lethality, delayed growth, ptosis, reduced exploratory activity, and seizure susceptibility. In some cases, transgenic rescue was superior to DOPS. However, allelic variation at the rs1611115 SNP had no impact on mRNA levels in any tissue. These results indicate that the human BAC contains all of the genetic information required for tissue-specific, functional expression of DBH and can rescue all measured Dbh deficiency phenotypes, but did not reveal an impact of the rs11115 variant on DBH expression in mice.
Author Notes
Keywords
Research Categories
  • Health Sciences, General
  • Biology, Genetics
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items